| New York Stock Exchange: COV
Covidien Plc engages in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates through three segments: Medical Devices, Pharmaceuticals and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. The Pharmaceuticals segment includes the development, manufacture and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, contrast products and radiopharmaceuticals. The Medical Supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products. The company was founded on June 29, 2007 and is headquartered in Dublin, Ireland.